MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Bone Health in Parkinson’s Disease

    E. Killeen, C. Gallagher, A. Mcdonough (Dublin, Ireland)

    Objective: Optimise bone health in people with Parkinson’s Disease Background: People with Parkinson’s Disease (PD) have an increased risk of osteoporosis and associated fractures due…
  • 2023 International Congress

    Late onset cerebellar ataxia in patients treated with VIM DBS

    C. Héraud, C. Alecu, D. Fontaine, A. Leplus, C. Giordana (NICE, France)

    Objective: To highlight the predictors for onset of cerebellar ataxia in patients treated with deep brain stimulation (DBS) of the Thalamic Ventral Intermediate Nucleus (VIM)…
  • 2023 International Congress

    Mitochondrial DNA copy number is associated with the severity of motor symptoms and dementia in Parkinson’s disease

    S. Jo, JH. Oh, S. Lee, J. Lee, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the diagnostic and prognostic role of blood mitochondrial DNA copy number (mtDNA-CN) measured by whole genome sequencing (WGS) in relation…
  • 2023 International Congress

    Exploring the effects of torsinA dysfunction in an iPSC-derived neuronal model of TOR1A dystonia

    S. Wrigley, N. Seto-Salvia, R. Brownstone, T. Warner (London, United Kingdom)

    Objective: To investigate phenotypic differences between iPSC-differentiated cortical neurons derived from patients with TOR1A dystonia compared to healthy controls. Background: Primary generalised dystonia is most…
  • 2023 International Congress

    Online education to promote compensation strategies for gait impairments in underserved Parkinson populations

    T. Capato, A. Tosserams, B. Bloem, J. Nonnekes (São Paulo, Brazil)

    Objective: Here, we explore the potential health benefits of using an online educational platform about compensation strategies for gait impairment in Parkinson’s disease (PD), in…
  • 2023 International Congress

    How does a diagnosis of Dementia with Parkinson’s influence future care provision?

    B. Mohamed, A. Rafeeq, J. Adenwalla, C. Thomas, S. Page, R. Lewis-Morton, T. Williams, S. Mahon (cardiff, United Kingdom)

    Objective: To describe the trajectory of Parkinson’s after the onset of dementia including setting of care, frailty levels and mortality rate. Background: Cardiff and Vale…
  • 2023 International Congress

    Trial site factor in Parkinson’s disease (PD) diary non-compliance

    P. Reksoprodjo (Prague, Czech Republic)

    Objective: In this analysis, we wanted to explore if PD diary non-compliance is distributed randomly in the dataset or if it has a tendency to…
  • 2023 International Congress

    Epidemiology of late-onset Parkinson’s disease in least-developed to Upper Middle-Income Countries: A Systematic Review and Meta-analysis

    G. Pereira, N. Soares, D. Teixeira-Dos-Santos, G. Marconi, D. Friedrich, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To conduct a meta-analysis of the epidemiological studies of Parkinson's disease (PD) performed in populations from least-developed to upper-middle-income countries. Background: While several epidemiology…
  • 2023 International Congress

    Association between Parkinson’s Disease and Atrial Fibrillation: A Literature Review

    W. Lintiso, N. Smati, E. Shamim (Gaithersburg, USA)

    Objective: Our literature review aims to summarize what has been reported in the literature with the next steps of looking at Kaiser Permanente (KP) to…
  • 2023 International Congress

    Neurofilament light chain, tau-PET and microglia-PET predict clinical progression in amyloid-negative corticobasal syndrome

    C. Palleis, N. Franzmeier, E. Weidinger, S. Katzdobler, N. Albert, O. Sabri, H. Barthel, R. Rupprecht, BS. Rauchmann, R. Perneczky, C. Haass, J. Levin, M. Brendel, GU. Hoeglinger (Munich, Germany)

    Objective: A head-to-head comparison of neuroimaging (tau-PET, microglia-PET, structural MRI) and plasma biomarker Neurofilament light chain (NfL) as prognostic tools for longitudinal clinical trajectories in…
  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24187 (not found)
  • #29526 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley